MHLW Orders Temporary Halt to Fuji Pharma’s Operations
This article was originally published in PharmAsia News
Executive Summary
Japan’s MHLW has ordered Fuji Pharma to suspend all business operations for 15 days in accordance with the Pharmaceutical Affairs Law after it decided the company had certified medical devices without sufficient examination.